Teufel Felix, Aggarwal Aastha, Chwastiak Lydia, Patel Vikram, Ali Mohammed K
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University, Atlanta, Georgia.
JAMA Psychiatry. 2024 Dec 1;81(12):1265-1269. doi: 10.1001/jamapsychiatry.2024.3419.
Depression is a leading contributor to mental health burdens globally and in India, the world's most populous country. National-level evidence on health coverage for adults with depression in India is lacking.
To estimate proportions of middle-aged and older adults with depression in India who used health care services, were diagnosed with depression, received treatment, and were in remission.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used individual-level survey data from the 2017-2018 Longitudinal Ageing Study in India, which represents all 36 states and union territories of India. Data were collected from April 1, 2017, to December 31, 2018. The sample included adults 45 years or older with data on depression, health care service use, depression diagnosis and treatment, and sociodemographic characteristics. The response rates were 96% for households and 87% for individuals. Data were analyzed from January 15, 2024, to July 23, 2024.
Major depressive episodes in the past 12 months were assessed using the Composite International Diagnostic Interview short-form symptom scale. We estimated self-reported health service use, depression diagnosis, and treatment for depression using sampling weights and stratified the data by rural vs urban residence. Participants were considered in remission if they received treatment and had fewer than 3 symptoms.
Among 65 121 participants, the median age was 57 years (IQR, 50-65 years); 53.3% were men and 46.7% were women. In terms of residence, 32.1% of participants resided in urban areas and 67.9% resided in rural areas. The weighted prevalence of depression was 8.6% (95% CI, 8.3%-8.9%). Of all participants with depression, 63.7% (95% CI, 62.0%-65.3%) had used any health services in the past year and 3.1% (95% CI, 2.6%-3.7%) had been diagnosed with depression; 1.6% (95% CI, 1.2%-2.0%) received some form of treatment (51% of those diagnosed) and 1.0% (95% CI, 0.7%-1.3%) were in remission (62% of those treated). The prevalence of depression was higher in rural areas (9.8% [95% CI, 9.4%-10.1%]) than in urban areas (6.2% [95% CI, 5.8%-6.7%]), although health service use, diagnosis, and treatment were lower in rural areas (61.2% [95% CI, 59.2%-63.1%], 2.6% [95% CI, 2.1%-3.3%], and 1.1% [95% CI, 0.8%-1.6%], respectively) than in urban areas (71.8% [95% CI, 68.5%-74.9%], 4.6% [95% CI, 3.5%-6.2%], and 3.0% [95% CI, 2.1%-4.4%], respectively). Among 29.6 million (95% CI, 28.6-30.6 million) middle-aged and older adults with depression across India, 29.1 million (95% CI, 28.2-30.1 million) were untreated, of whom 22.4 million (95% CI, 21.6-23.3 million) lived in rural areas.
The findings of this cross-sectional study suggest that despite health service use by nearly two-thirds of middle-aged and older Indian adults with depression, 97% of adults were undiagnosed, and approximately half of adults who were diagnosed were untreated. Greater awareness and systematic efforts to screen and treat persons with depression in India are needed.
抑郁症是全球及印度心理健康负担的主要成因,印度是世界上人口最多的国家。印度缺乏关于成年抑郁症患者医疗覆盖情况的国家级证据。
估计印度中老年抑郁症患者中使用医疗服务、被诊断为抑郁症、接受治疗以及病情缓解的比例。
设计、背景和参与者:这项横断面研究使用了2017 - 2018年印度纵向老龄化研究的个体层面调查数据,该研究涵盖印度所有36个邦和联邦属地。数据收集时间为2017年4月1日至2018年12月31日。样本包括45岁及以上的成年人,他们有关于抑郁症、医疗服务使用、抑郁症诊断和治疗以及社会人口学特征的数据。家庭回应率为96%,个人回应率为87%。数据于2024年1月15日至2024年7月23日进行分析。
使用综合国际诊断访谈简版症状量表评估过去12个月内的重度抑郁发作。我们使用抽样权重估计自我报告的医疗服务使用、抑郁症诊断和抑郁症治疗情况,并按城乡居住地对数据进行分层。如果参与者接受了治疗且症状少于3个,则被视为病情缓解。
在65121名参与者中,年龄中位数为57岁(四分位距,50 - 65岁);53.3%为男性,46.7%为女性。就居住地而言,32.1%的参与者居住在城市地区,67.9%居住在农村地区。抑郁症的加权患病率为8.6%(95%置信区间,8.3% - 8.9%)。在所有抑郁症患者中,63.7%(95%置信区间,62.0% - 65.3%)在过去一年中使用过任何医疗服务,3.1%(95%置信区间,2.6% - 3.7%)被诊断为抑郁症;1.6%(95%置信区间,1.2% - 2.0%)接受了某种形式的治疗(占诊断患者的51%),1.0%(95%置信区间,0.7% - 1.3%)病情缓解(占治疗患者的62%)。农村地区抑郁症患病率(9.8% [95%置信区间,9.4% - 10.1%])高于城市地区(6.2% [95%置信区间,5.8% - 6.7%]),尽管农村地区的医疗服务使用、诊断和治疗情况(分别为61.2% [95%置信区间,59.2% - 63.1%]、2.6% [95%置信区间,2.1% - 3.3%]和1.1% [95%置信区间,0.8% - 1.6%])低于城市地区(分别为71.8% [95%置信区间,68.5% - 74.9%]、4.6% [95%置信区间,3.5% - 6.2%]和3.0% [95%置信区间,2.1% -